Naproxen Infectopharm (Naproxen)

Naproxen works by inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for the production of prostaglandins. By lowering prostaglandin levels, it diminishes the inflammatory response, reduces pain signalling, and helps bring down elevated body temperature.

The appropriate dose of naproxen is determined by the prescribing healthcare professional based on the specific condition, patient age, weight, and overall health status. Dosage regimens may vary, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Naproxen is generally not recommended during the third trimester of pregnancy because it may affect fetal cardiovascular function. Safety during early pregnancy and lactation depends on clinical judgment; physicians should weigh potential benefits against risks and discuss alternatives when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, requesting trade or institutional credentials. The sales team will then reply with pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Both naproxen and ibuprofen belong to the NSAID class and share similar mechanisms of action. Naproxen has a longer half‑life, often allowing twice‑daily dosing, whereas ibuprofen typically requires three to four doses per day. Choice between them depends on individual response, dosing convenience, and specific safety considerations such as gastrointestinal or cardiovascular risk.

Naproxen should be stored at ambient temperature, preferably below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date printed on the packaging.

Naproxen is administered orally, usually as a tablet or capsule, and should be taken with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort for some patients.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, and acute kidney injury. Patients should seek immediate medical attention if they notice black stools, unexplained bruising, severe rash, swelling of the face or throat, or sudden loss of kidney function.

Naproxen should be avoided by individuals with known hypersensitivity to naproxen or other NSAIDs, those with active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or significant renal impairment. It is also contraindicated in the third trimester of pregnancy and in patients taking certain anticoagulants without close medical supervision.